Reports

332 Results (Page 1 of 14)

Malaysia Markets Research Reports

Pharmaceuticals

Malaysia Kidney Cancer Therapeutics Market Analysis

The Malaysia Kidney Cancer Therapeutics Market was valued at $10.11 Mn in 2023 and is predicted to grow at a CAGR of 5.06% from 2023 to 2030, to $14.29 Mn by 2030. The key drivers of this industry include the increasing prevalence of kidney cancer due to lifestyle and environmental factors, early detection, and advancement in diagnostic tools. The key players in the industry are Pfizer, Bayer, Novartis, Roche, Bristol Myers Squibb, and AstraZeneca among others.

PUBLISHED: Jun, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Healthcare Services

Malaysia Medical and Diagnostic Laboratory Service Market Analysis

This report presents a strategic analysis of the Malaysia Medical and Diagnostic Laboratory Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Malaysia Medical and Diagnostic Laboratory Service Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Medical Devices

Malaysia Dental Caries Detectors Market Analysis

The Malaysia Dental Caries Detectors Market was valued at $0.4 Mn in 2023 and is predicted to grow at a CAGR of 9.1% from 2023 to 2030, to $0.7 Mn by 2030. Malaysia Dental Caries Detectors Market is growing due to Increasing Dental Awareness and Education, Government Initiatives and Funding, and Advanced imaging and diagnostic. The market is primarily dominated by players such as EXIR Medical Clinic, Abeer Medical Group, Jeddah National Hospital, Sigal Clinics, Smile 360, Pacific Dental Services, Dental Services Group, Sirona Dental Systems, Dentsply Sirona, KaVo Kerr, Ivoclar Vivadent, and Planmeca.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Pharmaceuticals

Malaysia Clinical Nutrition for Diabetes Care Market Analysis

The Malaysia Clinical Nutrition for Diabetes Care Market was valued at $3.46 Mn in 2023 and is predicted to grow at a CAGR of 4.98% from 2023 to 2030, to $4.86 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Nestle Health Science, B.Braun, Novo Nordisk, and Perrigo Company among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Medical Devices

Malaysia Pharmacy Automation Device Market Analysis

The Malaysia Pharmacy Automation Device Market was valued at $8.8 Mn in 2023 and is predicted to grow at a CAGR of 10.1% from 2023 to 2030, to $17.3 Mn by 2030. Malaysia Pharmacy Automation Device Market is growing due to Growing Healthcare Expenses, Increased Medication Errors, Technological Advancements. The market is primarily dominated by players such as Amerisource Bergen Corporation, Accu-Chart Plus Healthcare Systems, Omnicell, Inc., McKesson Corporation; Pearson Medical Technologies, Baxter; Talyst, LLC, Scriptpro LLC.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Medical Devices

Malaysia Cardiac Pacemakers Market Analysis

The Malaysia Cardiac Pacemakers Market was valued at $6.51 Mn in 2023 and is predicted to grow at a CAGR of 3.4% from 2023 to 2030, to $8.22 Mn by 2030. The key drivers of this industry include healthcare expenditure, aging population, and technological advancements. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Pharmaceuticals

Malaysia Clinical Nutrition for Cancer Care Market Analysis

The Malaysia Clinical Nutrition for Cancer Care Market was valued at $9.1 Mn in 2023 and is predicted to grow at a CAGR of 5.24% from 2023 to 2030, to $12.9 Mn by 2030. The key drivers of the market include the increasing prevalence of cancer, increasing risk of malnutrition in oncology patients, and advancements in nutritional products. The prominent players of the Malaysia Clinical Nutrition for Cancer Care Market are Reckitt Benckiser, Nestlé Health Science, Abbott Nutrition, B. Braun Melsungen AG, and Fresenius Kabi, among others

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Pharmaceuticals

Malaysia Gram-Negative Infection Therapeutics Market Analysis

The Malaysia Gram-Negative Infection Therapeutics Market was valued at $23.9 Mn in 2023 and is predicted to grow at a CAGR of 6.1% from 2023 to 2030 to $36.2 Mn by 2030. Key drivers of this growth include increasing antimicrobial resistance (AMR), an aging population, and government initiatives. Major companies in this market include Sumitomo, Baxter, and other prominent firms.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Pharmaceuticals

Malaysia Home Infusion Therapy Market

The Malaysia Home Infusion Therapy Market was valued at $57.8 Mn in 2023 and is predicted to grow at a CAGR of 8.3% from 2023 to 2030, to $101 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the Malaysia Home Infusion Therapy Market are QMed Asia, Terumo Corporation, Nipro Corporation, Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

Pharmaceuticals

Malaysia Hepatitis A Therapeutics Market Analysis

The Malaysia Hepatitis A Therapeutics Market was valued at $1.19 Mn in 2023 and is predicted to grow at a CAGR of 2.2% from 2023 to 2030 to $1.40 Mn by 2030. Key drivers fuelling this market include the increasing prevalence of Hepatitis A, poor sanitation and hygiene practices, and lack of immunity among younger demographics. Pharmaniaga and F. Hoffmann-La Roche Ltd. are among the prominent companies contributing significantly to this sector.

PUBLISHED: Jul, 2024 | FORMAT: PPT | LAST UPDATED: Jul, 2024 | PRICE: $3999

OTC & Nutraceuticals

Malaysia Nutritional Supplements Market Analysis

By 2030, Malaysia's nutrition and supplements market is expected to reach a value of $1 Bn from $0.6 Bn in 2022, growing at a CAGR of 6.5% during 2022-30. Local players such as Careddi, Nutricia, and Nutrilite by Amway primarily dominates the market. The market for nutrition and supplements in Malaysia is primarily driven by e-commerce platforms and increasing consumer awareness of health and lifestyle. The Malaysia nutrition and supplements market in Malaysia is segmented by Type, Product, application, and Distribution Channel.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jun, 2024 | PRICE: $3999

Digital Health

Malaysia Blockchain Technology in Healthcare Market Analysis

This report presents a strategic analysis of Malaysia's Blockchain Technology in the Healthcare Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Malaysia Blockchain Technology in the Healthcare Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jun, 2024 | PRICE: $3999

Clinical Trials

Malaysia Growth Hormone Deficiency Clinical Trials Market Analysis

This report presents a strategic analysis of the Malaysia Growth Hormone Deficiency Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Malaysia Growth Hormone Deficiency Clinical Trials Market, offering unmatched value, accuracy and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jun, 2024 | PRICE: $3999

OTC & Nutraceuticals

Malaysia Over The Counter (OTC) Analgesics Market Analysis

This report presents a strategic analysis of the Malaysia Over The Counter (OTC) Analgesics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Malaysia Over The Counter (OTC) Analgesics Market, offering unmatched value, accuracy and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jun, 2024 | PRICE: $3999

Pharmaceuticals

Malaysia Compression Therapy Market Analysis

Malaysia Compression Therapy Market was valued at $6 Mn in 2022 and is estimated to reach $10 Mn in 2030, exhibiting a CAGR of 5.8% during the forecast period. The increasing occurrence of venous disorders such as leg ulcers, deep vein thrombosis, lymphedema, varicose veins, and blood clots is a major factor contributing to the expansion of the compression therapy market. Major participants in this sector include companies like Mölnlycke Health Care AB, Sigvaris, GC Medical Supply Co., Medi, Bauerfeind, Juzo, McKesson Corporation, Cardinal Health, BSN Medical, and Hartmann Group.

PUBLISHED: Jun, 2024 | FORMAT: PPT | LAST UPDATED: Jun, 2024 | PRICE: $3999

Digital Health

Malaysia Electronic Health Records Market Analysis

Malaysia's Electronic Health Records (EHR) market size was valued at $xx Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022 to 2030 and will reach $XX Bn in 2030. The market is segmented by product, application, and end user. The Malaysia EHR market will grow due to government initiatives to promote the adoption of EHRs. The key market players are Epic Systems Allscripts, McKesson, and others.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: May, 2024 | PRICE: $3999

Pharmaceuticals

Malaysia Chronic Pain Therapeutics Market Analysis

The Malaysia Chronic Pain Therapeutics Market is anticipated to experience a growth from $119 Mn in 2022 to $192 Mn by 2030, with a CAGR of 6.1% during the forecast period of 2022-2030. Malaysia is witnessing market growth due to factors such as the growing awareness of chronic pain, supported by governmental initiatives aimed at improving access to treatment and the escalating burden of chronic pain. The Malaysia Chronic Pain Therapeutics Market encompasses various players across different segments, including Pfizer, AstraZeneca, Sanofi, Merck, Roche, AbbVie, Novartis, Duopharma, Pharmaniaga, Healthex, etc., among various others.

PUBLISHED: May, 2024 | FORMAT: PPT | LAST UPDATED: May, 2024 | PRICE: $3999

Digital Health

Malaysia Artificial Intelligence (AI) in Healthcare Market Analysis

The Malaysia Artificial Intelligence (AI) In Healthcare Market is projected to grow from $0.01 Bn in 2022 to $0.22 Bn by 2030, registering a CAGR of 45.42% during the forecast period of 2022 - 2030. The market will be driven by the collaborative efforts from the government & private sectors and the introduction of structured regulations & guidelines for the use of AI in healthcare. The market is segmented by healthcare components & by healthcare applications. Some of the major players include Microsoft Healthcare, Naluri & Nova MSC Bhd.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: May, 2024 | PRICE: $3999

Medical Devices

Malaysia Biomaterials in Healthcare Market Analysis

Malaysia Biomaterials in Healthcare Market is expected to witness growth from $251 Mn in 2022 to $687 Mn in 2030 with a CAGR of 13.40% for the forecasted year 2022-30. Malaysia is seeing an increase in demand for cosmetic and plastic surgery due to growing disposable incomes and the availability of reasonably priced, high-quality healthcare services. Because biomaterials are frequently used in these procedures, manufacturers have chances to supply the market. The market is segmented by type and by application. Some key players in this market include Bioalpha Holdings Berhad, Biocon Sdn Bhd, Hovid Berhad, BASF SE, Johnson and Johnson, Medtronic and Evonik Industries.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: May, 2024 | PRICE: $3999

Pharmaceuticals

Malaysia ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis

Malaysia's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is projected to grow from $48 Mn in 2022 to $86 Mn in 2030 with a CAGR of 7.7% for the year 2022-30. The rise in the prevalence of ADHD cases in Malaysia and the demand for novel treatment options are responsible for the growth of the market. The Malaysia ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Royce Pharma, GoodScience, and Eli Lilly are some of the key players in the market.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: May, 2024 | PRICE: $3999

Healthcare Services

Malaysia Robotic Surgery Services Market Analysis

This report presents a strategic analysis of the Malaysia Robotic Surgery Services Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Malaysia Robotic Surgery Services Market, offering unmatched value, accuracy and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: May, 2024 | PRICE: $3999

Healthcare Services

Malaysia Dental Care Market Analysis

The Malaysia Dental Care Services Market size is at around $57.69 Mn in 2022 and is projected to reach $94.76 in 2030, exhibiting a CAGR of 6.4% during the forecast period (2022-2030). Malaysia spends 3.83% of its GDP on healthcare, for a total per capita distribution of $437, and provides universal healthcare to all citizens and legal residents, with tourists benefiting from competitive prices. This report by Insights10 is segmented by treatment type, age group, clinical setup, and by demography.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: May, 2024 | PRICE: $3999

Pharmaceuticals

Malaysia Dermatological Therapeutics Market Analysis

Malaysia Dermatological Therapeutics Market is at around $0.07 Bn in 2023 and is projected to reach $0.12 Bn in 2030, exhibiting a CAGR of 8.8% during the forecast period. The market is being driven by rising healthcare awareness, an increase in dermatological conditions, and technological advancements. The market is dominated by key players like Pharmaniaga Berhad, Duopharma Biotech Berhad, Almirall SA, Pfizer Inc., GlaxoSmithKline Plc, AbbVie Inc., Amgen Inc., Novartis AG, Roche, Sanofi, Bayer, and Johnson & Johnson.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: May, 2024 | PRICE: $3999

Healthcare Services

Malaysia Healthcare Insurance Market Analysis

The Malaysia healthcare insurance market is projected to grow from $3.26 Bn in 2022 to $5.94 Bn by 2030, registering a CAGR of 7.8% during the forecast period of 2022-2030. The main factors driving the growth would be increasing healthcare costs, government initiatives, a rise in medical tourism and technological advancements. The market is segmented by the component, provider, coverage, by health insurance plans and end-user. Some of the major players include Tune Protect, Etiqa Insurance, Hong Leong Assurance, Great Eastern Life Assurance and Generali.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: May, 2024 | PRICE: $3999

Pharmaceuticals

Malaysia Cholesterol Therapeutics Market Analysis

The Malaysia Cholesterol Therapeutics Market is anticipated to experience a growth from $39 Mn in 2022 to $49 Mn by 2030, with a CAGR of 2.8 % during the forecast period of 2022-2030. The key drivers in the Malaysia Cholesterol Therapeutics Market encompass a combination of lifestyle factors, government initiatives, pharmaceutical innovations, and demographic trends which collectively contribute to the growth and evolution of the market. The Malaysia Cholesterol Therapeutics Market encompasses various players across different segments such as Pfizer, AstraZeneca, Merck, Novartis, Sanofi, Bayer, Duopharma, Apex Healthcare, Pharmaniaga, Healthex, etc, among various others.

PUBLISHED: Apr, 2024 | FORMAT: PPT | LAST UPDATED: Apr, 2024 | PRICE: $3999

subscribe to our newsletter
up